Bookmark and Share

Rohit  Talwani
View Curriculum Vitae 

Rohit Talwani M.D.

Academic Title: Assistant Professor
Primary Appointment: Medicine
rtalwani@ihv.umaryland.edu
Location: Institute of Human Virology, N552
Phone: (410) 706-0612
Fax: (410) 706-4619

Personal History:

Education

1986-90: Bachelor of Arts, Biology, Cornell University, Ithaca, New York

1991-95: Doctor of Medicine. University of South Carolina, Columbia, South Carolina

1995-1996: Internship, Internal Medicine, Rush-Presbyterian-St. Luke’s Medical Center, Chicago, Illinois

1996-1998: Residency, Internal Medicine, Palmetto Richland Memorial Hospital/University of South Carolina School of Medicine, Columbia, South Carolina

1998-2000: Fellowship, Infectious Diseases, Rush-Presbyterian-St.Luke’s Medical Center/Cook County Hospital Joint Fellowship, Chicago, IL

Certifications

1996: Diplomate, National Board of Medical Examiners

1998-2008: Diplomate, American Board of Internal Medicine
       
2000-2010: Diplomate, American Board of Internal Medicine,
                 Subspecialty: Infectious Disease

Research Interests:

Viral Hepatitis

Clinical Speciality:

Infectious Diseases


Publications:

Journal Articles (Peer Reviewed)

Bryan CS, Talwani R, and Stinson MS. Penicillin Dosing for Pnemococcal Pneumonia. Chest 1997; 112: 1657-1664.

Talwani R and Horvath JA. Tuberculous Peritonitis in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis: Case Report and Review. Clinical Infectious Diseases July 2000; 31: 70-75.

Talwani R, Falusi OM, Mendes de Leon CF, Nerad JL, Rich S, Proia LA, Sha BE, Smith KY, and Kessler HA. Electron Beam Computed Tomography for Assessment of Coronary Artery Disease (CAD) in HIV-Infected Males Receiving Antiretroviral Therapy.  Journal of Acquired Immunodeficiency Syndromes June 2002; 30(2): 191-195.

Safdar A, Dommers Jr MP, Talwani R, and Thompson CR. Intracranial Perineuronal Extension of Invasive Mycosis- A Novel Mechanism of Disease Propagation by Aspergillus fumigatus. Clinical Infectious Diseases September 2002; 35: e50-53.

Postic B, Horvath JA, and Talwani R. Antiviral Treatment of Human Immunodefeciency Virus Infection: Update for 2003. Journal of the  South Carolina Medical Association June 2003; 99(6): 148-153.

Starnes CT, Talwani R, Horvath JA, Duffus WA, and Bryan CS.  Brucellosis in Two Hunt Club Members in South Carolina. Journal of the South Carolina Medical Association April 2004; 100: 45-47.

McCallum BJ, Amrol D, Horvath J, Inayat N, and Talwani R. A Case of Allergic Bronchopulmonary Aspergillosis Leading to Pneumonia with Unusual Organisms. Southern Medical Journal 2005;98: 1135-1138

Weems JJ, Steinberg JP, Filler S, Baddley JW, Corey GR, Sampathkumar P, Winston L, John JF,. Kubin CJ, Talwani R, Moore T, Patti JM, Hetherington S, Texter M, Wenzel E, Kelley VA, and Fowler VG. A phase II, randomized, double-blind, multi-center study comparing safety and pharmacokinetics of tefibazumab to placebo for the treatment of Staphylococcus aureus bacteremia  Antimicrobial Agents and Chemotherapy 2006; 50 (8): 2751-2755.

Book Chapters

Talwani R and Bryan CS. Host Considerations. In: Bryan CS, ed. Infectious Diseases in Primary Care. Philadelphia: W.B. Saunders and Company; 2002: 35-54.